Certara Corporation Launches Its Phoenix QT+ Cardiac Safety Assessment Tool

ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced the launch of its Phoenix® QT+™ cardiac safety assessment tool. This product provides data processing, statistical, and modeling capabilities to determine whether a drug candidate prolongs cardiac repolarization.

Help employers find you! Check out all the jobs and post your resume.